CEO Total Pay
$8.9M
FY2023 Summary Compensation, above median
The CEO earned $8.9M in FY2023 against median worker pay of $132,890 · Chemicals & Pharmaceuticals.
Data updated August 2026
Subscribe to LanzaTech Global, Inc. CEO pay filing updates (RSS)
Latest filing FY2023. This company's newest DEF 14A on file is for FY2023, not FY2025, so the figures on this page are from that earlier year and are not ranked against the FY2025 industry benchmark. Industry pages mark issuers like this one with a "Latest filing" label.
Answer first
Figures come from Section 953(b) Dodd-Frank DEF 14A disclosures - not estimates. View all Chemicals & Pharmaceuticals companies.
Exclusive CEO-to-median-worker bands across 153 complete latest-FY filings in SIC 28. Segments sum to the peer set, not this company's compensation pillar.
A component-level pay breakdown is not reported in LanzaTech Global, Inc.'s structured SEC pay-ratio disclosure. See our methodology →
LanzaTech Global, Inc. disclosed 67:1 CEO-to-worker pay and $8.9M CEO total in FY2023. the CEO earned 67× the median employee ($132,890) in FY2023.
Median employee $132,890 (ELITE-MED); MODEST · HEAVY stamps put about 67 median-wage years per CEO year.
CEO Total Pay
$8.9M
FY2023 Summary Compensation, above median
Pay Ratio
67:1
Near industry median
LanzaTech Global, Inc. disclosed 67:1 CEO-to-worker pay and $8.9M CEO total in FY2023. The structured pay-ratio disclosure reports the total without line-item components. Chemicals & Pharmaceuticals (SIC 28) median ratio is 42:1 across 168 FY2025 filers; LanzaTech Global, Inc.'s $8.9M CEO total is above the $7.9M industry median CEO pay.
LanzaTech Global, Inc. stamps MODEST · HEAVY · ELITE-MED; grant-date fair value (not realized pay) is what the DEF 14A reports. Open Chemicals & Pharmaceuticals peers.
Read our methodology - how this data is sourced, computed, and verified. LanzaTech Global, Inc. disclosed 67:1 CEO-to-worker pay and $8.9M CEO total in FY2023.
ABS(ceo_total_comp) peers first, then a SIC pole and a stamp-branched guide - not a fixed Related strip. This page stamps MODEST · HEAVY · ELITE-MED.
ABS(ceo_total_comp) peer at $8.9M (Δ $2K heavier vs LanzaTech Global, Inc.); STEEP · PAR-MED vs this page's MODEST · HEAVY · ELITE-MED.
ABS(ceo_total_comp) peer at $8.9M (Δ $6K lighter vs LanzaTech Global, Inc.); MID · PAR-MED vs this page's MODEST · HEAVY · ELITE-MED.
ABS(ceo_total_comp) peer at $8.9M (Δ $9K heavier vs LanzaTech Global, Inc.); STEEP · PAR-MED vs this page's MODEST · HEAVY · ELITE-MED.
ABS(ceo_total_comp) peer at $8.9M (Δ $19K heavier vs LanzaTech Global, Inc.); MID · HIGH-MED vs this page's MODEST · HEAVY · ELITE-MED.
LanzaTech Global, Inc. stamps MODEST · HEAVY · ELITE-MED inside SIC 28 - open the industry median board after the ABS peers.
See where MODEST · HEAVY packages sit on the national leaderboard after reading LanzaTech Global, Inc..
LanzaTech Global, Inc.'s MODEST stamp sits in the lower Item 402(u) band - start with how the ratio is disclosed before comparing peers.
Data currency: Executive compensation from SEC EDGAR DEF 14A proxy statements through fiscal year 2025, compiled and last refreshed August 2026. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.